MDA/ALS Center of Hope
11
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
45.5%
5 terminated/withdrawn out of 11 trials
54.5%
-32.0% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
EEG-Based Brain-Computer Interface Project for Individuals With Amyotrophic Lateral Sclerosis (ALS)
Role: collaborator
Cerebrospinal Fluid Repository
Role: collaborator
Compassionate Use of Ceftriaxone in Patients With Amyotrophic Lateral Sclerosis (ALS)
Role: collaborator
Amyotrophic Lateral Sclerosis (ALS) Tissue Donation Program
Role: collaborator
Non-Invasive Measurement of Gastrointestinal (GI) Motility in Patients With Amyotrophic Lateral Sclerosis (ALS)
Role: collaborator
Pennsylvania Consortium: Clinical Database
Role: collaborator
Quantitative Measurement of Nutritional Substrate Utilization in Patients With Amyotrophic Lateral Sclerosis (ALS)
Role: collaborator
Noninvasive Examination of the Work of Breathing in Patients With Amyotrophic Lateral Sclerosis (ALS).
Role: collaborator
Assessment of the Cyberlink Control System for Use by the Amyotrophic Lateral Sclerosis (ALS) Patient
Role: collaborator
Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient Population
Role: collaborator
Satisfaction Survey for Amyotrophic Lateral Sclerosis (ALS) Patients Comparing Rooms With and Without Assistive Technology
Role: collaborator
All 11 trials loaded